REMEDENT, INC.·4

Jun 18, 5:44 PM ET

Van Acker Philippe 4

4 · REMEDENT, INC. · Filed Jun 18, 2009

Insider Transaction Report

Form 4
Period: 2009-03-19
Van Acker Philippe
Chief Financial Officer
Transactions
  • Award

    Option

    2009-03-19+100,000100,000 total
    Exercise: $0.50From: 2009-03-19Exp: 2019-03-19Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]This option is fully vested and immediately exercisable.

Documents

1 file
  • 4
    for061709_ex.xmlPrimary